Concurrent Vestibular Activation and Postural Training Using Virtual Reality
NCT ID: NCT05942781
Last Updated: 2025-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
24 participants
INTERVENTIONAL
2024-04-15
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Vestibular Training on Postural Control of Healthy Adults Using Virtual Reality
NCT05941039
Dose of Vestibular Rehabilitation for Vestibular Hypofunction
NCT04851184
The Use of Virtual Reality for the Treatment of Visual Vertigo.
NCT03020654
Virtual Environments for Vestibular Rehabilitation
NCT04268745
Recovery of Visual Acuity in People With Vestibular Deficits
NCT00411216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vestibular activation training
A cross-over design will be used with group one receiving the training intervention for 7 days, a 6-day washout period, and a 7-day no-training period. Group two will follow the reverse sequence.
Vestibular training using VR followed by Control
A cross-over design will be used with group one receiving the training intervention for 7 days, a 6-day washout period, and a 7-day no-training period.
Control followed by Vestibular training using VR
Group two will follow the reverse sequence.
No training
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vestibular training using VR followed by Control
A cross-over design will be used with group one receiving the training intervention for 7 days, a 6-day washout period, and a 7-day no-training period.
Control followed by Vestibular training using VR
Group two will follow the reverse sequence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* This study requires participants to perform postural assessments including reactive balance following mechanical perturbations.
* Participants will also perform headshake activities and weight shift training in standing for 20 mins will mini breaks.
* Participants must be between the ages of 55-80.
Exclusion Criteria
* Concussion, vestibular, balance or oculomotor issues for the prior 6 months.
* Neuropathic conditions, particularly affecting the lower extremities. Participants with this issue will have sensory impairments which can affect their sensory assessment.
* Current musculoskeletal deficits including significant postural abnormalities (signs of spinal, pelvic and leg length discrepancies).
* Pain or limitations in neck range of motion.
* Recent (within 6 months) orthopedic surgery that impacts postural training.
* Visual Impairment ○ Participants must be able to see and follow targets in the virtual reality environment. Therefore, subjects must have 20/50 (corrected) vision. Subjects who are blind cannot participate.
55 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clarkson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kwadwo Appiah-Kubi
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clarkson Hall
Potsdam, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-30
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.